The effects of donepezil on nicotinic receptor status in dementia: A 123I-5IA-85380 SPECT study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 79, Issue 4, 2008, Pages 485-487

  Colloby, Sean J ^a   Pakrasi, S ^a   Perry, E K ^a   Pimlott, S L ^b   Wyper, D J ^c   Williams, E D ^d   McKeith, G ^a   O'Brien, J T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^d SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DONEPEZIL; METHYLTESTOSTERONE; NICOTINIC RECEPTOR; RADIOLIGAND;

AGED; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DRUG EFFECT; FEMALE; HUMAN; IN VIVO STUDY; INFORMED CONSENT; LETTER; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 41149152845     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2007.121780     Document Type: Letter

References (6)

1. Mamede M, Ishizu K, Ueda M, et al. Quantification of human nicotinic acetylcholine receptors with 123I-5IA SPECT. J Nucl Med 2004;45:1458-70.
2. Nordberg A, Lundgvist H, Hartvig P, et al. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment. Dement Geriatr Cogn Disord 1997;8:78-84.
3. McKhann G, Drachmen D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
4. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
5. O'Brien J T, Colloby SJ, Pakrasi S, et al. Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography. J Neurol Neurosurg Psychiatry 2007;78:356-62.
6. Kemp PM, Holmes C, Hoffmann S, et al. A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:1567-70.